Dark

ATHE
Alterity Therapeutics Limited
stock NASDAQ ADR

At Close

May 15, 2026 3:59:56 PM EDT

4.03USD-13.704%(-0.64)76,879

3.41Bid 4.79Ask 1.38Spread

Pre-market

May 15, 2026 9:16:30 AM EDT

4.45USD-4.719%(-0.22)6,322

After-hours

May 15, 2026 4:44:30 PM EDT

4.01USD-0.496%(-0.02)134

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

73.05M

Headquarters

Melbourne, Victoria, Australia

Industry

Biotechnology

Last Split

Jan 9, 20231for10reverse

ATHE Stats

Avg. Vol. 10 Day

23,935

Avg. Vol. 30 Day

23,574

Employees

Market Cap

73,046,547

Shares Out.

18,125,694

On/Off Exchange

47%/53%

6 Month Beta

1.25

1 Year Beta

1.22

2 Year Beta

0.50

3 Year Beta

0.26

52 Week Low

2.66

52 Week High

7.00

SMA50

3.98

SMA200

4.00

1 Week

-13.52%

1 Month

+8.04%

3 Month

+16.14%

6 Month

+4.95%

1 Year

+6.33%

2 Year

+97.55%

5 Year

-67.50%

Profile

alterity therapeutics limited researches and develops therapeutic drugs for the treatment of parkinsonian's disease and other neurodegenerative diseases in australia. the company's lead drug candidates is ath434 that has completed phase i clinical trial for the treatment of parkinson's disease. it is also developing pbt2 for used as an antimicrobial agent. the company was formerly known as prana biotechnology limited and changed its name to alterity therapeutics limited in april 2019. the company was founded in 1997 and is based in melbourne, australia.

ATHE Stock Summary

Alterity Therapeutics Limited (NASDAQ:ATHE) stock price today is $4.03, and today's volume is 76,879. ATHE is down -13.704% today. The 30 day average volume is 23,574. ATHE market cap is 73.05M with 18,125,694 shares outstanding.

.dark-mode .x7S0fK{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .x7S0fK{ color: #333333; background-color: white; border: 2px solid #333333; }ATHEAlterity Therapeutics Limitedstock NASDAQ ADR

ATHE Stock Summary

ATHE
Alterity Therapeutics Limited
stock NASDAQ ADR